Valentín Ortiz-Maldonado
@ValentinOrtizMD
Followers
2K
Following
4K
Media
86
Statuses
573
MD, PhD. Hematologist at @hospitalclinic, Barcelona. Visiting scholar at @fredhutch, Seattle. Doing my part through academic #CARTcell therapy.
Barcelona, España
Joined September 2018
RT @KlebanoffLab: 🤯Three (!!!) new papers today in @ScienceMagazine on the application of generative AI for the de novo design of peptide/H….
0
135
0
RT @WeizmannScience: We, the Weizmann Institute of Science community, deeply mourn the passing of Prof. Zelig Eshhar of the Department of I….
0
35
0
RT @drjgauthier: Excited to share this new publication in @Haematologica from our group @fredhutch investigating the impact of extramedulla….
0
3
0
RT @anita_Caballero: We are pleased and proud to share with you the results of our Phase 1 academic clinical trial with HSP-CAR30, publishe….
0
24
0
RT @nicola_maciocia: My PhD paper finally out today! Tweetorial coming but here is the link for now. Preclinical development of anti-CD21 c….
science.org
Fratricide-resistant anti-CD21 CAR-T cells are effective in preclinical models of T cell acute lymphoblastic leukemia (T-ALL).
0
8
0
RT @TheEBMT: 🔎 Have you seen this recent article?.📰 The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and su….
pubmed.ncbi.nlm.nih.gov
Immune monitoring of cell therapies is a complex and evolving topic, particularly in the rapid expanding field of chimeric antigen receptor T (CAR-T) cell applications. Defining essential, recommen...
0
6
0
RT @pagliuca_simona: Despite efforts to understand, we still do not know how to use it. A survey-review of the current landscape of immune….
0
16
0
RT @VJHemOnc: Thank you to @ValentinOrtizMD of @hospitalclinic for stopping by last week at #CART25 to share the results of the pivotal CAR….
vjhemonc.com
Valentín Ortiz-Maldonado, MD, Hospital Clinic Barcelona, Barcelona, Spain, shares the results of the pivotal CART19-BE-02 trial (NCT04778579), a multicenter trial investigating varnimcabtagene...
0
8
0
RT @DrMarcosdelima: @ValentinOrtizMD visited us @OSUCCC_James yesterday - fantastic summary of the very successful and impactful work condu….
0
3
0
Grateful for the kind invitation to speak about in-house #CARTcell therapy at the @OSUCCC_James Grand Rounds. Special thanks to @DrMarcosdelima for his kind invitation and to all the crew at @OSUHematology for the great and insightful discussions on improving access to #ATMPs.
0
5
43
RT @drjgauthier: À propos of the current NIH and Medicare cuts. I’m growing increasingly concerned as to my ability to continue building my….
0
4
0
Congratulations @LauraSamplesMD and @mshadman for leading this work!.
Just out @BloodJournal :. Outcome of #CART therapy for #burkitt #lymphoma. Another great internatioal collaboration led by @LauraSamplesMD . @fredhutch @uwmnewsroom .
0
0
2
RT @DrShadeO: Congratulations @ekimblepl on the @ASTCT New Investigator Award! Excited to see new approaches to CAR T cell therapy in AML.….
0
7
0
@EHA_Hematology @TheEBMT Grateful to my amazing colleagues from the CART19-BE-02 trial and @hospitalclinic, especially from the Immunotherapy, Hematology, Pharmacology, and Clinical Trials Unit, for their invaluable contributions to this teamwork. Looking forward to the next steps in CAR-T access!.
0
0
15
Truly honoured to receive the 5th EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy 2025! It’s been a fantastic #CART25 congress in Strasbourg! @EHA_Hematology @TheEBMT
17
11
90
RT @gulderenesra: Wrapping up #CART25 on a high note! @ValentinOrtizMD absolutely rocks it with the winning abstract on the CART19-BE-02 mu….
0
7
0
Round 2: Outcomes of second CAR T-cell therapies in R/R B-ALL by Dr. Susana Rives #ASH24. 💫. Another wonderful presentation on behalf of the GoCART coalition.@GoCARTcoalition .@EHA_Hematology .@TheEBMT
0
4
19
How transmembrane domains in CAR T-cell therapy *do* matter: great presentation by Dr. Rodriguez-Lobato at #ASH24.@DrGerLobato .@hospitalclinic .@hematoclinicbcn
0
8
43
Excellent presentation by Dr. Giorgio Ottaviano on the RWE of alloHCT after CART19 in B-ALL: a study on behalf of the GoCART coalition.🙌 .#ASH24.@GiorgiOttaviano @GoCARTcoalition @EHA_Hematology @TheEBMT
0
7
26
Check this review on impact of age on T-cell mediated therapies: fantastic work led by the greats Nina Neuendorf @neuendorff_nr and Fabian Ullrich @fa_ulle #JITC.
New #JITC review: Impact of immunological aging on T cell-mediated therapies in older adults with multiple myeloma and lymphoma @Qfa_ulle @BroeckelmannPJ @ValentinOrtizMD @neuendorff_nr
0
3
15